Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium

Clinical trial NCT00080795 · COMPLETED

Trial details

NCT number: NCT00080795
Sponsor: M.D. Anderson Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Bladder Cancer Transitional Cell Cancer of the Renal Pelvis and Ureter Urethral Cancer

Start date: 2001-07-01
Primary completion: 2006-05-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.